MFDS — authorised 25 April 2023
- Marketing authorisation holder: BIOGEN MA
- Status: likely_approved
🇰🇷 Qalsody in South Korea
MFDS authorised Qalsody on 25 April 2023
Marketing authorisation
Qalsody in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Rare Disease approved in South Korea
Frequently asked questions
Is Qalsody approved in South Korea?
Yes. MFDS authorised it on 25 April 2023.
Who is the marketing authorisation holder for Qalsody in South Korea?
BIOGEN MA holds the South Korean marketing authorisation.